Perjeta, which is pertuzumab, is a significant advancement in managing HER2-positive mammary cancer. The medication works by targeting a distinct pathway which helps cancer cells multiply . Differing from some other HER2-targeted therapies, pertuzumab doesn't directly block the HER2 receptor itse